Login

Promore Pharma Interview | April 2023 - Jonas Ekblom, CEO, Promore Pharma 00:00:00

Share On Facebook Share On Twitter

Promore Pharma Interview | April 2023 - Jonas Ekblom, CEO, Promore Pharma

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Exploring Innovative ETF Opportunities with John Porter | John Porter, CIO , Newton Investment Management .
00:10:00
Five Considerations for Third-Party AI Tools | Cooley AI | Tracy Rubin - Partner, Cooley LLP
00:10:00
Capral Limited at the ASX Small and Mid-Cap Conference with Proactive | MR TONY DRAGICEVICH., CHIEF EXECUTIVE OFFICER AND MANAGING DIRECTOR, CAPRAL LTD
00:10:00
Building World Class Business from India|Sri Viswanath,General Partner,Coatue
00:10:00
Support founders at the earliest stages of company-building|David Schenkein,General Partner,GV
00:00:00
Jan Adriaan (Arjan) Haverhals Chief Executive Officer and President, Milestone Scientific Inc
00:10:00
Invests in the next generation of tech enabled consumer and enterprise businesses|Daniel Broukhim,Co-Founder and Partner,Green Meadow Ventures
00:10:00
Evaluating the Chinese Currency and Bond Market Dynamics | Richard Tang, CEO ,  ICBC Credit Suisse Asset Management.
00:10:00
Embracing Philotimo: A Journey of Values and Impact
00:10:00
AAC Technologies Group Publicity | Pan Zhengmin, CEO, AAC Technologies Holdings Inc2018:HKG
00:10:00
Sanjit Biswas, Samsara co-founder and CEO, joins 'TechCheck' to discuss the company's first day of trading as the stock opens at $23.
00:10:00
Financial technology will create a better tomorrow|Jake Gibson,Founding Partner,Better Tomorrow Ventures

© 2026 Nehu